The primary objective of the study is to identify demographic and non-spirometric clinical features predictive of the asthma-COPD overlap population. The study aims to explore and identify characteristics of the Asthma-COPD Overlap Syndrome (ACOS) patient's clinical profile that enable clinical differentiation from subjects with a primary diagnosis of either asthma alone (without persistent obstruction) or COPD alone (without reversibility). The study is designed as a targeted medical history survey which consists of a 41-item questionnaire, which will be administered by a qualified health care practitioner at the time a subject's medical history is taken. The questionnaire has been developed to elicit specific details of the respiratory history, including the following: bronchodilator use, disease progression, variation in symptoms, atopic history, symptom triggers, vagal bias, burden of disease, symptom presentation, co morbidities and age of onset. In addition, demographic information, standard medical history, co morbidity and spirometric results will also be obtained and analyzed in conjunction with the questionnaire results. Approximately 1000 subjects are required for the study.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Summary of spirometry data: forced expiratory volume in one second (FEV1) and forced vital capacity (FVC)
Timeframe: Day 1
Summary of spirometry data: Reversibility
Timeframe: Day 1
Number of participants with response to Bronchodilators (Questionnaire Items 1 and 2)
Timeframe: Day 1
Number of participants with disease progression (Questionnaire Item 3)
Timeframe: Day 1
Number of participants with Variation in symptoms (Questionnaire Items 4-10)
Timeframe: Day 1
Number of participants with atopic history (Questionnaire Items 11 and 12)
Timeframe: Day 1
Number of participants with atopic history (Questionnaire Items 13-15)
Timeframe: Day 1
Number of participants with vagal bias (Questionnaire Items 16 and 17)
Timeframe: Day 1
Number of participants with burden of disease (Questionnaire Items 18-24)
Timeframe: Day 1
Number of participants with symptom presentation (Questionnaire Items 25-34)
Timeframe: Day 1
Number of participants with emotional response by Sex (Questionnaire Items 35 and 36)
Timeframe: Day 1
Summary of age of onset (Questionnaire Items 37 and 38)
Timeframe: Day 1
Number of participants with perception of respiratory disease (Questionnaire Items 39-40)
Timeframe: Day 1
Number of participants with clinical features most helpful in diagnosis (Questionnaire Item 41)
Timeframe: Day 1